| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.4M | +25.9% | +10.4% |
| Cost of Revenue | $7.2M | — | +7.0% |
| Gross Profit | $7.3M | +33.1% | +14.1% |
| R&D Expense | $1.4M | — | -15.6% |
| SG&A Expense | $2.9M | — | +9.5% |
| Operating Income | $771K | — | +5240.0% |
| Pre-tax Income | $789K | — | +1027.1% |
| Income Tax | $23K | — | -54.9% |
| Net Income | $766K | +167.7% | +3931.6% |
| EPS (Basic) | $0.08 | +172.7% | — |
| EPS (Diluted) | $0.07 | +163.6% | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $18.8M | -7.8% | +32.9% |
| Accounts Receivable | $9.0M | +41.8% | -0.4% |
| Inventory | $9.6M | -11.8% | -33.6% |
| Current Assets | $38.7M | -0.2% | -0.5% |
| Total Assets | $47.9M | +7.0% | +8.4% |
| Current Liabilities | $12.4M | -5.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$946K | — | -487.6% |
| Capital Expenditures | $80K | — | +700.0% |
| Investing Cash Flow | -$560K | — | -5500.0% |
| Financing Cash Flow | -$69K | — | -38.0% |
| Free Cash Flow | -$1.0M | — | -500.0% |
| -3.0% |
| Total Liabilities | $15.6M | +14.3% | +18.0% |
| Stockholders' Equity | $32.3M | +3.8% | +4.4% |